BMY

Bristol Myers Squibb Co
67.225
-0.015 (-0.02%)

Period:

Draw Mode:

Volume 2,386,469
Bid Price
Ask Price
News -
Day High 67.81

Low
65.275

52 Week Range

High
81.435

Day Low 67.215
Company Name Stock Ticker Symbol Market Type
Bristol Myers Squibb Co BMY NYSE Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.015 -0.02% 67.225 13:00:22
Open Price Low Price High Price Close Price Prev Close
67.48 67.215 67.81 67.24
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
26,800 2,386,469 $ 67.55 $ 161,214,878 - 65.275 - 81.435
Last Trade Time Type Quantity Stock Price Currency
13:00:22 100 $ 67.225 USD

Bristol Myers Squibb Co Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 141.09B 2.10B 2.10B $ 46.16B $ 6.40B 2.95 22.60
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ 2.19 3.43% 04/06/23 -258.22k 0.30%

more financials information »

Bristol Myers Squibb News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No BMY Message Board. Create One! See More Posts on BMY Message Board See More Message Board Posts

Historical BMY Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week66.3067.8165.7666.8912,397,3440.9251.4%
1 Month71.2771.9865.27568.018,244,163-4.05-5.68%
3 Months73.1875.1865.27570.888,252,786-5.96-8.14%
6 Months69.7481.43565.27573.208,910,861-2.52-3.61%
1 Year71.4881.43565.27574.0110,654,078-4.26-5.95%
3 Years47.2281.43545.7665.5511,596,85420.0142.37%
5 Years66.5481.43541.1960.3211,946,8690.6851.03%

Bristol Myers Squibb Description

Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Unlike some of its more diversified peers, Bristol has exited several nonpharmaceutical businesses to focus on branded specialty drugs, which tend to support strong pricing power.